YARTEMLEA Trademark

Trademark Overview


On Friday, March 29, 2024, a trademark application was filed for YARTEMLEA with the United States Patent and Trademark Office. The USPTO has given the YARTEMLEA trademark a serial number of 98475095. The federal status of this trademark filing is REGISTERED as of Tuesday, August 27, 2024. This trademark is owned by Omeros Corporation. The YARTEMLEA trademark is filed in the Pharmaceutical Products category with the following description:

Biochemical preparations for medical purposes, namely, for the treatment of endothelial diseases and disorders, renal diseases, transplant complications, and hematological, neurological, immunological and inflammation-related disease and disorders; chemical preparations for medical purposes, namely, for the treatment of endothelial diseases and disorders, renal diseases, transplant complications, and hematological, neurological, immunological and inflammation-related disease and disorders; therapeutic preparations for medical purposes, namely, for the treatment of endothelial diseases and disorders, renal diseases, transplant complications, and hematological, neurological, immunological and inflammation-related disease and disorders
yartemlea

General Information


Serial Number98475095
Word MarkYARTEMLEA
Filing DateFriday, March 29, 2024
Status700 - REGISTERED
Status DateTuesday, August 27, 2024
Registration Number7489136
Registration DateTuesday, August 27, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 11, 2024

Trademark Statements


Goods and ServicesBiochemical preparations for medical purposes, namely, for the treatment of endothelial diseases and disorders, renal diseases, transplant complications, and hematological, neurological, immunological and inflammation-related disease and disorders; chemical preparations for medical purposes, namely, for the treatment of endothelial diseases and disorders, renal diseases, transplant complications, and hematological, neurological, immunological and inflammation-related disease and disorders; therapeutic preparations for medical purposes, namely, for the treatment of endothelial diseases and disorders, renal diseases, transplant complications, and hematological, neurological, immunological and inflammation-related disease and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 29, 2024
Primary Code005
First Use Anywhere DateSunday, April 30, 2023
First Use In Commerce DateSunday, April 30, 2023

Trademark Owner History


Party NameOmeros Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98119

Party NameOmeros Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeattle, WA 98119

Party NameOmeros Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98119

Trademark Events


Event DateEvent Description
Friday, March 29, 2024NEW APPLICATION ENTERED
Tuesday, May 7, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 29, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 3, 2024ASSIGNED TO EXAMINER
Wednesday, May 22, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 11, 2024PUBLISHED FOR OPPOSITION
Tuesday, June 11, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 27, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, August 27, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED